News

The drug tovorafenib may halt the growth of or shrink some childhood brain tumors, according to a clinical trial published in Nature Medicine.

Through molecular twin precision oncology platform, Cedars-Sinai cancer investigators identify biomarkers that outperform standard test and could expand the promise of precision medicine.

New WSU research could ultimately help extend the lives of those with prostate cancer, one of the leading causes of cancer deaths among men.

Multiple myeloma, a blood cancer, may be caused by viruses and therefore may be fought by antivirals, reports new research.

Researchers from King’s College London (KCL) suggest that fertilized chicken eggs could provide a low-cost option for cancer imaging studies, potentially helping to resolve some ethical and economic issues.

A "game-changing" leukemia treatment is being tested on children who can't tolerate chemotherapy, and results so far have been promising.

Non-cancerous cells called stromal cells may be useful in assessing these tumors’ potential to spread, and may even be targets for future prostate cancer treatments

Cervical cancer frequently resists treatment. The researchers’ machine learning algorithm could help scientists better understand why this and other forms of cancer resist chemotherapy.

Combining three different sources of genetic information has allowed researchers to further understand why only some people with a common mutation go on to develop rare blood cancer.

Breast cancer cells can consume their surroundings to overcome starvation and continue cell growth, according to a new study, which describes a previously unknown method of cancer cell survival.